The role of nuclear factor-kappa B in pulmonary diseases
- PMID: 10807839
- DOI: 10.1378/chest.117.5.1482
The role of nuclear factor-kappa B in pulmonary diseases
Abstract
Nuclear factor-kappa B (NF-kappaB) is a family of DNA-binding protein factors that are required for transcription of most proinflammatory molecules, including adhesion molecules, enzymes, cytokines, and chemokines. NF-kappaB activation seems to be a key early event in a variety of cell and animal model systems developed to elucidate the pathobiology of lung diseases. The purpose of this short review is to describe what is known about the molecular biology of NF-kappaB and to review information that implicates NF-kappaB in the pathogenesis of lung disease, including ARDS, systemic inflammatory response syndrome, asthma, respiratory viral infections, occupational and environmental lung disease, and cystic fibrosis.
Comment in
-
The role of nuclear factor-kappa B activation in airway inflammation following adenovirus infection and COPD.Chest. 2001 Apr;119(4):1294-5. Chest. 2001. PMID: 11296213 No abstract available.
Similar articles
-
Role of NF-kappa B in the pathogenesis of diabetes and its associated complications.Pharmacol Rep. 2009 Jul-Aug;61(4):595-603. doi: 10.1016/s1734-1140(09)70111-2. Pharmacol Rep. 2009. PMID: 19815941 Review.
-
The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy.Am J Respir Med. 2003;2(3):211-9. doi: 10.1007/BF03256650. Am J Respir Med. 2003. PMID: 14720003 Review.
-
Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat.Hepatology. 1999 Oct;30(4):934-43. doi: 10.1002/hep.510300402. Hepatology. 1999. PMID: 10498645
-
Nuclear factor-kappa B and its role in inflammatory lung disease.Chem Biol Interact. 2021 Aug 25;345:109568. doi: 10.1016/j.cbi.2021.109568. Epub 2021 Jun 25. Chem Biol Interact. 2021. PMID: 34181887 Review.
-
Nuclear factor-κB: a key regulator in health and disease of lungs.Arch Immunol Ther Exp (Warsz). 2011 Oct;59(5):335-51. doi: 10.1007/s00005-011-0136-z. Epub 2011 Jul 26. Arch Immunol Ther Exp (Warsz). 2011. PMID: 21786215 Free PMC article. Review.
Cited by
-
IKK2/NFkB signaling controls lung resident CD8+ T cell memory during influenza infection.Nat Commun. 2023 Jul 19;14(1):4331. doi: 10.1038/s41467-023-40107-1. Nat Commun. 2023. PMID: 37468506 Free PMC article.
-
Pneumocystis Exacerbates Inflammation and Mucus Hypersecretion in a Murine, Elastase-Induced-COPD Model.J Fungi (Basel). 2023 Apr 7;9(4):452. doi: 10.3390/jof9040452. J Fungi (Basel). 2023. PMID: 37108906 Free PMC article.
-
Mechanism of lnRNA-ICL involved in lung cancer development in COPD patients through modulating microRNA-19-3p/NKRF/NF-κB axis.Cancer Cell Int. 2023 Apr 3;23(1):58. doi: 10.1186/s12935-023-02900-2. Cancer Cell Int. 2023. PMID: 37013587 Free PMC article.
-
The COPD-Associated Polymorphism Impairs the CFTR Function to Suppress Excessive IL-8 Production upon Environmental Pathogen Exposure.Int J Mol Sci. 2023 Jan 24;24(3):2305. doi: 10.3390/ijms24032305. Int J Mol Sci. 2023. PMID: 36768629 Free PMC article.
-
α1-adrenoceptor stimulation ameliorates lipopolysaccharide-induced lung injury by inhibiting alveolar macrophage inflammatory responses through NF-κB and ERK1/2 pathway in ARDS.Front Immunol. 2023 Jan 6;13:1090773. doi: 10.3389/fimmu.2022.1090773. eCollection 2022. Front Immunol. 2023. PMID: 36685596 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
